Fish Vaccine Market, By Vaccine Type (Killed Vaccine, Inactivated Vaccine, Attenuated Vaccine, Toxoid Vaccine, Subunit Vaccine, Conjugate Vaccine, Recombinant Vector Vaccines), By Indication (Furunculosis, Vibriosis, Yersiniosis, Enteric septicaemia, Others), By Route of Administration (Injection, Immersion, Spray, Oral), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)

Published In : Feb 2025

Code : CMI5184

Pages :177

Formats :

Excel and PDF

Industry : Biotechnology

Fish Vaccine Market Size and Trends

Global fish vaccine market is estimated to be valued at USD 410.0 million in 2025 and is expected to reach USD 764.6 million by 2032, exhibiting a compound annual growth rate (CAGR) of 9.3% from 2025 to 2032.

Fish Vaccine Market Key Factors

To learn more about this report, Request sample copy

Rising cases of viral infections are encouraging fish farmers and government organizations to adopt preventive measures. Furthermore, increasing adoption of advanced vaccine administration techniques and growing aquaculture industry can boost demand for high quality and effective fish vaccines. However, high vaccination cost and lack of infrastructure and awareness in developing nations can hamper the market growth. Increasing R&D investment by major players for development of novel vaccines and growing consumer preference for safe seafood are expected to create lucrative opportunities for the fish vaccine market in the near future.

Global Aquaculture Boom

Rising demand for fish and other seafood products across the world has led to tremendous growth in commercial aquaculture industry in the past few years. Due to growing world population and increased seafood consumption, farmed fish production needs to keep pace to satisfy this demand. Many countries and private firms have extensively invested in developing commercial fish farming operations to boost fish yields. Salmon, carp, tilapia, shrimp and other popular varieties are now extensively cultivated in fish farms and ponds on a large industrial scale. However, intensive aquaculture increases risk of diseases that can spread rapidly and devastate entire stocks, if left uncontrolled. Vaccines have emerged as a critical tool for fish farmers to immunize their stocks and minimize losses from endemic diseases. As the aquaculture sector expands to new geographies and scales new heights to meet seafood demand, the dependence on reliable fish health management solutions including vaccines will increase substantially.